Paramyxovirus serotype 1 (PMV-1), the etiologic agent of Newcastle disease, is an important cause of morbidity in falcons in the Middle East. To determine whether a commercial, oil-based, inactivated poultry vaccine produces humoral response in falcons, we vaccinated 38 young, unvaccinated gyr-peregrine hybrid falcons (Falco rusticolis × Falco peregrinus) and monitored antibody response for a 45-day period after vaccination. To determine whether immunity is vertically transmitted, we additionally tested the yolks of 15 unfertile eggs of falcons vaccinated 5 months previously. All testing was done by commercial enzyme-linked immunosorbent assay for PMV-1 antibody designed for use in poultry. In the vaccinated falcons, serum antibody levels to avian PMV-1 increased by day 14 after vaccination, and titers continued to increase until day 45 when the study ended. Five percent of birds failed to seroconvert. Adult female falcons vaccinated with inactivated vaccine produced eggs with high antibody levels. The inactivated vaccine caused no detectable adverse affects in the gyr-peregrine hybrids.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 22 • No. 3